News | Quality Assurance (QA) | July 08, 2019

PTW to Feature New Dosimetry Technology at AAPM 2019

Offerings will include new water phantom for MR-guided radiotherapy, modular patient and machine QA systems

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system

The Beamscan 3-D water phantom with the Varian Halcyon radiotherapy system. Image courtesy of PTW.

July 8, 2019 — At this year’s American Association of Physicists in Medicine (AAPM) show, July 14-18 in San Antonio, Texas, PTW will exhibit its full range of dosimetry solutions for magnetic resonance-guided radiotherapy (MRgRT), beam data commissioning and stereotactic quality assurance (QA).

PTW will exhibit and demonstrate its latest technology and most recent product developments including:

  • Beamscan MR 3-D water phantom – The first 3-D water phantom for MR-guided radiotherapy, according to the company, available in two models for Elekta Unity and ViewRay MRIdian. Beamscan MR 3-D is pending U.S. Food and Drug Administration (FDA) 510(k) clearance and is not available for sale in the U.S.;
  • Beamscan 3-D water phantom – Fast to set up and easy to use for all acceptance testing and commissioning needs, now available for the Halcyon system;
  • Octavius 4-D modular patient and machine QA systems – For the latest radiotherapy techniques, including Halcyon, stereotactic radiosurgery (SRS) and MRgRT. Also introducing Octavius Detector 1600 SRS for 3-D dose verification of complex SRS/SBRT (stereotactic body radiation therapy) treatment plans;
  • Ruby phantom – A new modular stereotactic verification phantom with multiple inserts for comprehensive system QA, linear accelerator (linac) QA and patient QA:
  • StarCheck arrays – High-resolution ionization chamber arrays for comprehensive, TG-142-compliant linac QA, available in three models for standard (25 x 25 cm²), large (40 x 40 cm²) and magnetic fields;
  • microSilicon diode detector – The new silicon diode detector for small photon and all electron fields; and
  • Track-it 2.0 QA data management software – Versatile, web-based QA data management software that integrates QA data from different sources, devices and sites into a single platform.

PTW is hosting a Lunch and Learn symposium for AAPM attendees on Monday, July 15. The event will feature the following presenters:

  • Jochem Wolthaus, Ph.D., a medical physicist at the University Medical Center Utrecht, will present “The Development and Experience of the first MR-compatible 3-D Scanning Water Tank for Acceptance, Commissioning and QA measurements in an MRI-LINAC”; 
  • Dan Nicewonger, a medical physicist at the MD Anderson Cancer Center in San Antonio, will present “QA Data Flow in Modern Radiotherapy Departments”; and
  • Sharon Thompson, a medical physicist from the Maimonides Cancer Center, Brooklyn, N.Y., will present “Challenges of Beam Data Collection and Validation of Halcyon during Commissioning.”

For more information: www.ptwdosimetry.com

Related Content

Members of Congress from both sides of the aisle issued a series of oversight letters to the Centers for Medicare and Medicaid Services (CMS) in recent months to urge the Agency to adjust its proposed radiation oncology advanced alternative payment model (RO Model)

Image by whitfieldink from Pixabay

News | Radiation Oncology | November 13, 2019
November 13, 2019 — Members of Congress from both sides of the aisle issued a series of oversight letters to the...
Bladder Abdomen Pelvis image with DLCExpert
News | Artificial Intelligence | November 07, 2019
November 7, 2019 — Mirada Medical, a global leader in...
Liver cancer tumor scanning using an MRI
News | Proton Therapy | November 04, 2019
November 4, 2019 – Two new studies support and inform the use of proton radiation therapy to treat patients with hepa
Advanced Radiation Therapy Upgrades AccuBoost Digital Brachytherapy Platform
News | Brachytherapy Systems, Women's Healthcare | October 23, 2019
At the 2019 American Society for Radiation Oncology (ASTRO) annual meeting, Sept. 15-18 in Chicago, Advanced Radiation...
Major Radiology Organizations Publish Ethics of AI in Radiology Statement
News | Artificial Intelligence | October 22, 2019
Experts in the use of artificial intelligence (AI) in radiology, from many of the world’s leading radiology, medical...
MD Anderson and Varian Partner to Optimize Radiation Oncology Treatment
News | Treatment Planning | October 18, 2019
The University of Texas MD Anderson Cancer Center and Varian announced a new strategic collaboration to develop an...
Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Low four-year rates of gastrointestinal (13.6 percent) and urologic issues (7.6 percent) suggest hypofractionated proton therapy as an alternative to traditional radiotherapy to reduce toxicity.

Feature | Prostate Cancer | October 16, 2019 | By Jeff Zagoudis
Radiation therapy is an important tool in the clinician’s armamentarium for treatment of localized, early-stage prost